Business · 17/10/2001Updated: 10/17/2026 · 1 min read
FDA Corrects Notice on Synercid Patent Extension Review Period
Summary
The FDA is correcting a notice published in the Federal Register on September 21, 2001, due to an error in determining the regulatory review period for Synercid, a medication that was previously approved.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →